tiprankstipranks
Theralase Technologies (DE:TTX)
FRANKFURT:TTX
Germany Market
TTX
Theralase Technologies
RESEARCH TOOLSreports

Theralase Technologies (TTX) Financial Statements

1 Followers

Theralase Technologies Financial Overview

Theralase Technologies's market cap is currently €42.81M. The company's EPS TTM is €-0.0105; its P/E ratio is -16.57; Theralase Technologies is scheduled to report earnings on May 29, 2026, and the estimated EPS forecast is €>-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Dec 24Dec 23Mar 23Mar 22
Income Statement
Total RevenueC$ 816.47KC$ 1.03MC$ 1.07MC$ 1.14MC$ 780.64K
Gross ProfitC$ 241.51KC$ 554.03KC$ 562.13KC$ 628.17KC$ 309.94K
Operating IncomeC$ -4.18MC$ -4.29MC$ -4.59MC$ -5.20MC$ -4.52M
EBITDAC$ -3.91MC$ -3.96MC$ -4.25MC$ -4.90MC$ -4.31M
Net IncomeC$ -4.12MC$ -4.26MC$ -4.57MC$ -5.25MC$ -4.42M
Balance Sheet
Cash & Short-Term InvestmentsC$ 182.91KC$ 268.76KC$ 43.91KC$ 1.51MC$ 3.69M
Total AssetsC$ 3.49MC$ 3.25MC$ 3.28MC$ 4.16MC$ 5.94M
Total DebtC$ 458.05KC$ 293.87KC$ 386.88KC$ 473.62KC$ 35.72K
Net DebtC$ 275.14KC$ 25.11KC$ 342.97KC$ -1.03MC$ -3.66M
Total LiabilitiesC$ 1.72MC$ 1.18MC$ 1.37MC$ 1.07MC$ 874.79K
Stockholders' EquityC$ 1.78MC$ 2.07MC$ 1.91MC$ 3.09MC$ 5.07M
Cash Flow
Free Cash FlowC$ -3.33MC$ -3.35MC$ -4.11MC$ -5.20MC$ -4.13M
Operating Cash FlowC$ -3.29MC$ -3.33MC$ -4.07MC$ -5.13MC$ -4.03M
Investing Cash FlowC$ -48.94KC$ -19.97KC$ -37.27KC$ -70.41KC$ -100.82K
Financing Cash FlowC$ 3.25MC$ 3.57MC$ 2.65MC$ 3.02MC$ -57.37K
Currency in CAD

Theralase Technologies Earnings and Revenue History

Income Statement >

Theralase Technologies Debt to Assets

Balance Sheet >

Theralase Technologies Cash Flow

Cash Flow >

Theralase Technologies Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >